Effectiveness of NESA in the Treatment of Cancer Survivors

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 19, 2024

Primary Completion Date

September 19, 2025

Study Completion Date

December 19, 2025

Conditions
Cancer Survivors
Interventions
DEVICE

Non-invasive Neuromodulation

Patients receive non-invasive neurostimulation through the Nesa device

DEVICE

Placebo Non-invasive Neuromodulation

The same protocol described for the experimental group will be applied, but electrical stimulation device which will be previously manipulated and tested with an oscilloscope so that they do not emit electrical currents.

Trial Locations (1)

07320

RECRUITING

Gutmotion, Santa Maria del Camí

All Listed Sponsors
lead

Aníbal Báez Suárez

OTHER